Medication info
Lansotone Capsule 15 mg (Lansoprazole Granules)

Lansotone Capsule 15 mg (Lansoprazole Granules)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole Granules›185mg / 1 capsule
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
This medication is a hard capsule filled with white granules that are white to pale brown.
Packaging
28 capsules (7 capsules/PTP x 4)
Approval status
Active

MFDS item code 200210756 · Approved 2002.02.27 · Insurance code 645400180

Summary

Main use
Treatment and prevention of ulcers and eradication of Helicobacter pylori; treatment of reflux disease; suppression of gastric acid hypersecretion
Who takes it
Adults · Children
Adult dose
This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice as much juice or more to ensure the entire dose is taken, and drink immediately. Do not chew or crush the contents after opening this medicine. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy following treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction in the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies from patient to patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. When administering more than 120 mg per day, divide the dose. Dose adjustment is necessary in elderly patients because clearance of this medicine is reduced. Do not exceed a daily dose of 30 mg. Use with caution, including dose adjustment, in patients with hepatic impairment, as metabolism and excretion of this medicine may be delayed.
Child dose
Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of ulcers and eradication of Helicobacter pylori; treatment of reflux disease; suppression of gastric acid hypersecretion

  • Active duodenal ulcers
  • active benign gastric ulcers
  • duodenal ulcers
  • NSAID-induced gastric ulcers
  • symptoms associated with gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion conditions.
View approved original text

This medication is used for the short-term treatment of active duodenal ulcers and benign gastric ulcers. It also helps in eradicating Helicobacter pylori to prevent recurrence of duodenal ulcers. It can be utilized as maintenance therapy after treatment to assist in the continuous management of ulcers. It is effective for the treatment of gastric ulcers induced by NSAIDs and in reducing risks. It is applied for the short-term treatment of gastroesophageal reflux disease and erosive esophagitis and for maintenance post-treatment. Lastly, it is used in managing pathological hypersecretion conditions such as Zollinger-Ellison syndrome. This medication improves the treatment and management of various gastrointestinal diseases.

How to take

Adult dose

This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice as much juice or more to ensure the entire dose is taken, and drink immediately. Do not chew or crush the contents after opening this medicine. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy following treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction in the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies from patient to patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. When administering more than 120 mg per day, divide the dose. Dose adjustment is necessary in elderly patients because clearance of this medicine is reduced. Do not exceed a daily dose of 30 mg. Use with caution, including dose adjustment, in patients with hepatic impairment, as metabolism and excretion of this medicine may be delayed.

Child dose

Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with a history of specific allergic reactions. Caution should be taken, especially in cases of hypersensitivity to this medication or any of its components, or to benzimidazole derivatives. Pregnant or breastfeeding women should preferably avoid this medication. Patients with impaired liver function, the elderly, children, and nursing mothers should use this medication cautiously. If serious allergic reactions or symptoms such as skin rash or difficulty breathing develop during treatment, stop taking the medication immediately and consult a doctor. Long-term use may cause vitamin B12 deficiency or liver function abnormalities, so regular check-ups are required. Also, since this medication can interact with other medications, it is essential to inform your doctor or pharmacist of any other medications you are currently taking. Particular caution should be exercised when taken with HIV medications, certain antibiotics, or anticoagulants. If symptoms such as diarrhea, abdominal pain, or fever occur, consider the possibility of gastrointestinal infection and consult a healthcare provider immediately. This medication suppresses gastric acid secretion, which may increase the risk of fractures with long-term use, so it is important to manage bone density. Dizziness or drowsiness may occur, requiring caution when driving or operating machinery. In cases of overdose, gastric lavage or treatment according to symptoms may be necessary, and this medication is not removed by hemodialysis. Keep this medication out of reach of children and do not transfer it to another container to maintain quality.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial edema, shortness of breath, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic hepatic dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membrane colitis, bloody stool, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, cancer, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, malaise, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stool, enteritis, gastritis, gastrointestinal abnormality, gastrointestinal disease, gastrointestinal bleeding, loss of appetite, gastric stones, pyloric spasm, cholelithiasis, constipation, dry mouth, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, stool discoloration, abdominal distension, gastric nodules, gastric fundic polyps, gastroenteritis, gastrointestinal bleeding, hematemesis, increased appetite, increased salivation, anal bleeding, stomatitis, tongue disease, glossitis, gum bleeding, thang zhang, colitis, vomiting, nausea, gastrointestinal candidiasis, rectal disease, rectal bleeding, diabetes, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disease, joint disease, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia gravis, ptosis, synovitis, anxiety, amnesia, unease, indifference, delirium, depression, dizziness, syncope, hallucinations, hemiplegia, exacerbation of hostility, decreased libido, increased libido, neurosis, sensory disturbance, abnormal cognition, seizures, dementia, depersonalization, diplopia, hyperactivity, hypertonia, sensory deficit, insomnia, sleep disturbances, drowsiness, tremors, acne, hair loss, itching, rash, contact dermatitis, dry skin, nail disease, skin cancer, skin disease, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eye, ear disease, eye disease, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, eye pain, otitis media, taste alterations, tinnitus, tunnel vision, urinary disorders, renal pain, penile disease, testicular disorders, urethral pain, polyuria, frequent urination, urinary retention, menstrual irregularity, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, renal stones, abdominal pain, hepatotoxicity, vomiting, pancreatitis, taste disturbances, aplastic anemia, leukopenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorder, urinary retention, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, increased total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. Keep at room temperature between 1°C and 30°C. Proper storage can help maintain the medication's effectiveness and safety over time.

Appearance and packaging

Appearance

This medication is a hard capsule filled with white granules that are white to pale brown.

Package unit

28 capsules (7 capsules/PTP x 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.